https://dxm-atlas.org/en/interactions/terbinafine-oral/
CompareKey points for this combination
A human study used a probe substance to assess CYP2D6 activity and showed inhibition by terbinafine [23]. High confidence in direct evidence (D) refers to that enzyme-test result. The test did not measure total DXM exposure over time (AUC) or clinical outcomes.
General concepts in this text
Enzyme
A protein that helps chemical transformations in cells.
A transformation can build or break down a substance.
Sources: Enzyme
- OpenStax: General Neurochemistry Principles · Introduction to Behavioral Neuroscience, published 2024-11-13
CYP2D6
One of the CYP enzymes involved in processing drugs.
Inhibition means reducing enzyme activity; it can change the processing of drugs.
Sources: CYP2D6
- IUPHAR Pharmacology Education Project: Drug metabolism · Live page accessed 2026-10-12; revision label unavailable
AUC
Area under the graph of a drug’s plasma concentration over time.
It combines concentration and time to describe drug exposure over an interval.
Sources: AUC
- Canadian Society of Pharmacology and Therapeutics: AUC · Live institutional page read 2026-10-13; separate revision label unavailable
Drug exposure
Description of how much of a medicine is present in the body, using its concentrations.
Cmax describes the concentration peak; AUC combines concentrations over time.
Sources: Drug exposure
- FDA: Examples of Drugs that Interact with CYP Enzymes and Transporter Systems · Live institutional page read 2026-10-13; separate revision label unavailable
How well is this understood?
Mechanism confidence: high
Confidence in the mechanism: high
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodConfidence in human DXM data: high
Confidence in direct human evidence involving DXM: high
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodHow do the substances interact?
Can the amount reaching the body change?
ⓘ
CYP2D6
One of the CYP enzymes involved in processing drugs.
Inhibition means reducing enzyme activity; it can change the processing of drugs.
Sources: CYP2D6
- IUPHAR Pharmacology Education Project: Drug metabolism · Live page accessed 2026-10-12; revision label unavailable
What remains unknown?
*Direct metabolic-phenotyping evidence of CYP2D6 inhibition. High confidence H concerns that measured endpoint [23].
Sources
Check the review’s wording
*Direct metabolic-phenotyping evidence of CYP2D6 inhibition. High confidence H concerns that measured endpoint [23].
- [23] Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects · Open publication
Evidence and sources
Research publication
[23] · Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects · 2001
Finding [23]
- What was found?
*Direct metabolic-phenotyping evidence of CYP2D6 inhibition. High confidence H concerns that measured endpoint [23].
Scientific review: 8. Antihistamines and modifiers of metabolism